Danaher Corp (DHR)

Thermo Fisher Scientific reports Q3 2025 adjusted earnings of $5.79 per share, sales of $11.12 billion and raised its full-year guidance.

Washington D.C., October 22, 2025 – Danaher Corporation (NYSE: DHR) is currently experiencing a wave of positive sentiment, with its stock price widely expected to rise following a robust third-quarter 2025 earnings report. The life sciences and diagnostics giant exceeded analyst expectations, fueling an optimistic outlook from market experts and

The company's third-quarter earnings pleased investors.

Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 7.5% in the afternoon session after the company reported third-quarter 2025 financial results that surpassed analyst expectations for revenue and profit. Danaher announced revenue grew 4.4% from the previous year to $6.05 billion, ahead of the $6.01 billion consensus estimate. The company’s adjusted earnings per share also came in strong at $1.89, higher than the anticipated $1.72. The report was not entirely positive, however, as management's revenue guidance for the upcoming fourth quarter of $6.70 billion came in below Wall Street's expectations of $7.03 billion. Despite the weaker outlook, investors appeared to focus on the current quarter's outperformance, sending the stock higher.

Danaher Corporation (NYSE:DHR) shares are rising Tuesday after the company reported better-than-expected third-quarter financial results.

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, while optimism across earnings kept industrial stocks powering higher and pushed the Dow Jones to fresh record highs.

Shares surged Tuesday after the medical research company beat third-quarter forecasts on the back of its bioprocessing division.

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session.

Danaher's Q3 2025 earnings beat estimates at $1.89 per share, but revenue guidance for Q4 fell short of Wall Street expectations.

Diversified science and technology company Danaher (NYSE:DHR) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 4.4% year on year to $6.05 billion. On the other hand, next quarter’s revenue guidance of $6.70 billion was less impressive, coming in 4.7% below analysts’ estimates. Its non-GAAP profit of $1.89 per share was 9.8% above analysts’ consensus estimates.

Diversified science and technology company Danaher (NYSE:DHR) will be announcing earnings results this Tuesday morning. Here’s what to expect.

Johnson Controls is transforming into a key AI infrastructure provider by solving the critical cooling and power challenges of modern data centers.

Enpro Inc. (NYSE: NPO) acquiring AlpHa Measurement Solutions and Overlook Industries for $280 million in cash.

Healthcare stocks haven't been very popular this year. It could be a great time to buy some of the industry's leaders.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.